rimcazole has been researched along with 3-[(4-chlorophenyl)-phenylmethoxy]-8-methyl-8-azabicyclo[3.2.1]octane in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffman, BT; Katz, JL; Kopajtic, T; Newman, AH | 1 |
| Brodbeck, R; Husbands, SM; Kieltyka, A; Newman, AH; Robarge, MJ; Thurkauf, A | 1 |
2 other study(ies) available for rimcazole and 3-[(4-chlorophenyl)-phenylmethoxy]-8-methyl-8-azabicyclo[3.2.1]octane
| Article | Year |
|---|---|
2D QSAR modeling and preliminary database searching for dopamine transporter inhibitors using genetic algorithm variable selection of Molconn Z descriptors.
Topics: Algorithms; Binding, Competitive; Carrier Proteins; Databases, Factual; Dopamine; Dopamine Plasma Membrane Transport Proteins; Ligands; Membrane Glycoproteins; Membrane Transport Proteins; Models, Molecular; Nerve Tissue Proteins; Quantitative Structure-Activity Relationship; Radioligand Assay; Reproducibility of Results; Software | 2000 |
Design and synthesis of [(2,3-dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as novel ligands selective for the dopamine D3 receptor subtype.
Topics: Amides; Animals; Binding, Competitive; CHO Cells; Combinatorial Chemistry Techniques; Cricetinae; Drug Design; Fluorenes; Humans; Ligands; Piperazines; Radioligand Assay; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Structure-Activity Relationship | 2001 |